Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials

Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials

Abstract Aims Sacubitril‐valsartan has been shown to have superior effects over angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in patients with heart failure (HF) and hypertension. The efficacy and safety of sacubitril‐valsartan in patients with HF are controversial. We p...

Full description

Bibliographic Details
Main Authors: Hongzhou Zhang, Tieqiu Huang, Wen Shen, Xiuxiu Xu, Pingping Yang, Dan Zhu, Haiyang Fang, Hongbing Wan, Tao Wu, Yanqing Wu, Qinghua Wu
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
Heart failure
Sacubitril‐valsartan
Meta‐analysis
Online Access:https://doi.org/10.1002/ehf2.12974

Internet

https://doi.org/10.1002/ehf2.12974

Similar Items